Reports
Reports
Epistaxis is a medical disease that causes sporadic nasal bleeding out of any of the nostrils. Depending on where the bleeding starts, this clinical disorder is typically divided into posterior and anterior epistaxis. The New England Journal of Medicine estimates that 60% of people around the world had experienced epistaxis at least once in their entire life, and that 6% of these patients needed medical attention. Epistaxis is more common in people above 35 years of age and in children under the age of ten. Increasing prevalence of the condition is likely to drive growth of the global epistaxis market in the years to come.
Epistaxis is typically brought on by local trauma, such as nose picking or nasal infection. Epistaxis can be brought on by dry weather, an absence of humidity in the air, or extended exposure to dry air. Epistaxis is more likely to occur in those on anticoagulant drugs like aspirin, warfarin, clopidogrel, or any other. Epistaxis can also be caused by other risk factors including cocaine use, allergy and non-allergic rhinitis, hypertension, alcohol misuse, and congenital bleeding issues. Devices for epistaxis are used to treat nosebleeds. Nasal tampons, nasal catheters, and various epistaxis devices are available, which is expected to drive revenue-generation opportunities in epistaxis industry.
Types, application, and region are important market parameters that have been taken into account whilst segmenting the global epistaxis market.
Ascend Wellness Holdings and Siemens Healthineers struck a collaboration contract in January 2022 to increase the testing capacity of Ascend's new California facility.
Some of the major players in the global epistaxis market are as mentioned below
Below-mentioned developments, restraints, opportunities, and drivers are anticipated to characterize the global Epistaxis market
Hypertension is the main etiology of epistaxis and is highly prone to bleeding. As per the Center for Disease Control and Prevention (CDC), amongst women aged 20 years to 44 years, high blood pressure occurs in about 1 in every 12 to 17 pregnancy cases. In addition to that, air pollution is another significant component that is likely to contribute to future market demand for epistaxis treatment. Epistaxis is more likely to occur if individuals breathe contaminated air. Over 90% of people inhale polluted air, as per the World Economic Forum. The global market for epistaxis is projected to grow as a result of all these factors.
Furthermore, epistaxis is one of the health issues that affects adults, children, and the elderly more typically and is more likely to develop in scorching summers or bitterly cold winters. In less humid conditions, the nasal membrane dries up and abnormal bleeding results. The demand for diverse epistaxis treatment solutions to address abnormal nosebleed issues is being driven by a rise in these nosebleed incidences during extremely cold, hot, dry, or less humid conditions globally.
One of the main factors propelling the North America epistaxis market and rendering it one of the most profitable regions in the global market is the region's established healthcare sector. Besides, rising consumer knowledge of different techniques to treat nose bleeding issues like epistaxis is expected to trigger growth of the regional market.
The US is likely to see an increase in demand for novel products for the management of epistaxis as a result of recent advances in medical research and the development of new pharmaceuticals and therapies to successfully address a variety of health-related concerns. In addition to that, the shifts in American consumers' lifestyles, such as increasing prevalence of smoking and rise in air pollution, is likely to increase the risk of epistaxis.
N/A
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Epistaxis Market
